ClinicalThought

Share

Program Content

Activities

  • MF After Ruxolitinib
    Managing Patients With Myelofibrosis Following Ruxolitinib Failure
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 07, 2019

    Expires: October 05, 2020

  • ASH 2019: MPNs
    ASH 2019 Preview: Key Expert-Selected MPN Studies
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 02, 2019

    Expires: November 30, 2020

  • FAQ: MPNs
    Experts Answer Frequently Asked Questions on the Management of Myeloproliferative Neoplasms
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 16, 2020

    Expires: January 14, 2021

Faculty

cover img faculity

Raajit K. Rampal, MD, PhD

Associate Member
Director, MPN and Rare Hematologic Malignancies Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Alessandro M. Vannucchi, MD

Full Professor of Hematology
Department of Experimental and Clinical Medicine
University of Florence
Director
Center of Research and Innovation of Myeloproliferative Neoplasms
AOU Careggi
Florence, Italy

cover img faculity

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Celgene

CTI BioPharma Corp

Geron